Orient Paper & Industries Modifies Capital Expenditure Project for Tissue Machine Installation at Amlai Facility
Orient Paper & Industries Limited has modified its capital expenditure project at the Amlai facility, replacing certain modernization initiatives with a new tissue machine installation. The revised project cost has increased from Rs. 125 crores to Rs. 213 crores, adding 23,400 TPA capacity to existing operations. The company has discontinued a separate Rs. 475 crores modernization project, having spent Rs. 239 crores, to align with its new strategic focus on advanced tissue manufacturing capabilities.

*this image is generated using AI for illustrative purposes only.
Orient Paper & Industries Limited has announced a strategic modification to its capital expenditure project at the Amlai manufacturing facility in Madhya Pradesh. The Board of Directors, in their meeting held on 27th March, 2026, approved significant changes to the original modernization plan, focusing on advanced tissue manufacturing capabilities.
Project Modification Details
The company has revised its capital expenditure strategy, replacing certain previously planned modernization initiatives with the installation of a new tissue machine incorporating advanced technology. This modification builds upon the original project disclosed on 5th August, 2025, representing a strategic shift in the company's manufacturing approach.
| Parameter | Original Plan | Revised Plan |
|---|---|---|
| Project Scope | Modernisation/de-bottlenecking | Installation of new tissue machine |
| Investment | Rs. 125 crores | Rs. 213 crores (approx.) |
| Capacity Addition | Not specified | 23,400 TPA |
| Implementation Period | Not specified | Extended up to 2027-28 |
Capacity Enhancement and Investment
The modified project will add 23,400 TPA capacity to the existing 1,00,000 TPA at the Amlai facility. The full capacity is expected to be operational during FY 2029-30. The total project cost has been revised upward from Rs. 125 crores to approximately Rs. 213 crores, with financing planned through a mix of debt and internal accruals.
Strategic Rationale
The Board cited several factors driving this modification:
- Evolving market dynamics in the paper industry
- Changing demand patterns and increasing emphasis on product quality
- Cost optimization requirements
- Need for adoption of advanced and efficient manufacturing technologies
The company expects the revised project to deliver improved operational efficiency, enhanced production capacity, superior product quality, and better cost competitiveness, thereby strengthening its position in the tissue paper segment.
Impact on Existing Projects
In a related development, the Board decided to discontinue the modernization project that was approved on 15th March, 2023. This project had incurred and obligated Rs. 239 crores out of its sanctioned outlay of Rs. 475 crores. The decision aligns with the company's revised strategic direction focusing on tissue manufacturing capabilities.
Implementation Timeline
The modified project timeline extends the implementation period up to 2027-28, with the new tissue machine and related infrastructure expected to include expenses for maintenance, modernization, and energy cost optimization. The project aims to achieve product mix optimization while improving operational efficiency and productivity.
Historical Stock Returns for Orient Paper & Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.19% | +3.00% | -13.80% | -38.66% | -32.15% | -37.03% |
How will the increased investment from Rs. 125 crores to Rs. 213 crores impact Orient Paper's debt-to-equity ratio and financial leverage over the next two years?
What competitive advantages could the new tissue manufacturing technology provide against established players in India's tissue paper market?
Will the discontinuation of the Rs. 475 crore modernization project result in asset write-offs or impairment charges in upcoming quarterly results?






























